Hangzhou Huadong Medicine Group Kangrun Pharmaceutical

FDA inspection history in Xiaofeng Town, Anji, China, 2015

1
Form 483

Every document, by year

  • Form 483

2015: one Form 483.

The story so far

Built from the dates and citations on the documents themselves.

  1. 2015One Form 483, at Xiaofeng Town, Anji, China.

Cited most

Across all Hangzhou Huadong Medicine Group Kangrun Pharmaceutical observations on file

The complete Hangzhou Huadong Medicine Group Kangrun Pharmaceutical file.

All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.

$99

The documents one by one, while the file is prepared

See the documents

Sites

Documents

1 on file, newest first
DateDocumentPrice
2015-01-22483 Form 483$99

Investigators on these documents

Jeffrey D. Meng (1)

FEI number 3008465758 · most recent document Jan 22, 2015

About Hangzhou Huadong Medicine Group Kangrun Pharmaceutical

How many FDA Form 483s has Hangzhou Huadong Medicine Group Kangrun Pharmaceutical received?

FDA Intel has 1 Form 483 on file for Hangzhou Huadong Medicine Group Kangrun Pharmaceutical; the most recent is dated Jan 22, 2015.

When was Hangzhou Huadong Medicine Group Kangrun Pharmaceutical last inspected by FDA?

The most recent FDA inspection document on file for Hangzhou Huadong Medicine Group Kangrun Pharmaceutical is a Form 483 dated Jan 22, 2015, for the site in Xiaofeng Town, Anji, China.

What did FDA cite at Hangzhou Huadong Medicine Group Kangrun Pharmaceutical?

The regulations cited most in the observations on file for Hangzhou Huadong Medicine Group Kangrun Pharmaceutical are 21 CFR 211.160 (General requirements), 2 times; 21 CFR 211.68 (Automatic, mechanical, and electronic equipment), 2 times; 21 CFR 211.100 (Written procedures; deviations), 1 time.